Creative Medical Technology Holdings, Inc. (CELZ)
Market Cap | 7.35M |
Revenue (ttm) | 137,754 |
Net Income (ttm) | -7.80M |
Shares Out | 14.08M |
EPS (ttm) | -4.61 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 183,824 |
Open | 0.570 |
Previous Close | 0.553 |
Day's Range | 0.498 - 0.570 |
52-Week Range | 0.330 - 5.145 |
Beta | 4.90 |
Analysts | Buy |
Price Target | 10.20 (+1,853.65%) |
Earnings Date | n/a |
About CELZ
Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine to treat chronic lower back pain; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona. [Read more]
Financial Performance
Financial StatementsAnalyst Forecast
According to 7 analysts, the average rating for CELZ stock is "Buy." The 12-month stock price forecast is $10.2, which is an increase of 1,853.65% from the latest price.
News

Creative Medical Technology Holdings Announces FDA Clearance of Investigational New Drug (IND) Application for AlloStem™, a Novel Cell Therapy for the Treatment of Type 1 Diabetes
AlloStem™ represents the first novel allogenic cellular therapy in the dorsal artery of the pancreas in the United States PHOENIX , Nov. 3, 2022 /PRNewswire/ -- Creative Medical Technology Holdings,...

Creative Medical Technology Holdings Develops AlloStem™ Clinical Cell Line
PHOENIX , Oct. 20, 2022 /PRNewswire/ -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ), a biotechnology company focused on a regenerative approach to immunotherapy, endocrinology, urology, ...

Creative Medical Technology Announces Peer Reviewed Publication of Positive Results for StemSpine® Study
--Two-Year Follow-Up Results Confirm Significant Efficacy and No Serious Adverse Effects in Patients who Underwent the StemSpine® Procedure for Treating Chronic Lower Back Pain -- PHOENIX , Sept. 26, ...

Creative Medical Technology Announces Positive Top-Line Results for OvaStem® Pilot Study
Three-Year Follow Up Results Confirm Significant Efficacy and No Serious Adverse Effects in Patients receiving OvaStem® Procedure for Treating Primary Ovarian Insufficiency PHOENIX , July 28, 2022 /PR...

Creative Medical Technology Holdings Announces Agreement with Greenstone Biosciences, Inc. for Development of a Next Generation iPSC Pipeline for its ImmCelz® Immunotherapy Platform
PHOENIX , June 15, 2022 /PRNewswire/ -- Creative Medical Technology Holdings, Inc. ("Creative Medical Technology" or the "Company") (NASDAQ: CELZ), a leading commercial stage biotechnology company foc...

Creative Medical Technology Announces $17 Million Private Placement Priced At-The-Market Under Nasdaq Rules
PHOENIX , April 29, 2022 /PRNewswire/ -- Creative Medical Technology Holdings, Inc. ("Creative Medical Technology" or the "Company") (NASDAQ: CELZ), a leading commercial stage biotechnology company fo...

Creative Medical Technology Announces Progress in Developing a Reproducible Clinical Grade of the Company's ImmCelz® Product
-- Initial experiments demonstrate expeditious potential for high-volume production of ImmCelz® with consistent potency -- PHOENIX , April 20, 2022 /PRNewswire/ -- Creative Medical Technology Holdings...

Creative Medical Technology to Showcase CaverStem® at American Urological Association Annual Meeting - Largest and Most Prominent Gathering of Urologists in the World
PHOENIX , April 12, 2022 /PRNewswire/ -- Creative Medical Technology Holdings, Inc. ("Creative Medical Technology" or the "Company") (NASDAQ: CELZ), a leading commercial stage biotechnology company fo...

Creative Medical (CELZ) Up 82% on Stem Cell Treatment Data
Creative Medical Technology (CELZ) reports positive follow-up data from a pilot study evaluating StemSpine, a patented stem cell treatment for chronic lower back pain.

Why Is Creative Medical Technology (CELZ) Stock Up Today?
Creative Medical Technology announced positive results concerning its StemSpine procedure. Here's what you should know as CELZ stock rises.

Why Creative Medical Technology Shares Are Soaring
Creative Medical Technology Holdings Inc (NASDAQ: CELZ) shares are trading higher Wednesday after the company announced top-line results for its follow-up StemSpine pilot study. The initial study show...
Creative Medical Shares Soar On Positive Data from StemSpine Pilot Study
Creative Medical Technology Holdings (NASDAQ: CELZ) has announced positive two-year follow-up data from its StemSpine pilot study.

Creative Medical Technology Announces Positive Top-Line Results for StemSpine® Pilot Study
--Two-Year Follow-Up Results Confirm Significant Efficacy and No Serious Adverse Effects in Patients Using StemSpine® Procedure for Treating Chronic Lower Back Pain -- PHOENIX, March 23, 2022 /PRNewsw...

Creative Medical Technology to Participate in the 34th Annual Roth Conference
PHOENIX, March 8, 2022 /PRNewswire/ -- Creative Medical Technology Holdings, Inc. ("Creative Medical Technology" or the "Company") (NASDAQ: CELZ), a leading commercial stage biotechnology company focu...

Creative Medical Technology Appoints Sahil Nock as Chief Commercial Officer
PHOENIX, Ariz. , March 2, 2022 /PRNewswire/ -- Creative Medical Technology Holdings, Inc. ("Creative Medical Technology" or the "Company") (NASDAQ: CELZ), a leading commercial stage biotechnology comp...
8 Top Penny Stocks to Watch Today: EVGRF, PTE, BLCT, GNPX, AFI, CELZ, AUVI, WAVE
We're diving into the top penny stocks to watch today as several names in the space see major movement on Monday alongside heavy trading. The post 8 Top Penny Stocks to Watch Today: EVGRF, PTE, BLCT, ...

CELZ Stock: 5 Things to Know About Trending Penny Stock Creative Medical Technology
Creative Medical Technology (CELZ) stock is taking off on Monday despite a lack of news from the commercial-stage biotechnology company. The post CELZ Stock: 5 Things to Know About Trending Penny Stoc...

Creative Medical Technology Holdings, Inc. Prices $16 Million Public Offering and Uplisting to the Nasdaq Capital Market
PHOENIX, Dec. 3, 2021 /PRNewswire/ -- Creative Medical Technology Holdings, Inc. (the "Company") (NASDAQ: CELZ), a commercial stage biotechnology company focused on a regenerative approach to Immunoth...

Creative Medical Technology Holdings Announces Implementation of Reverse Stock Split in Preparation for Planned Uplisting to The Nasdaq Capital Market
PHOENIX, Nov. 9, 2021 /PRNewswire/ -- (OTC-CELZ) Creative Medical Technology Holdings, Inc. (the "Company"), a commercial stage biotechnology company focused on immunology, urology, neurology and orth...